Andrology July 2022 PMID 35438843

Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review.

Bin Guo, Jiao-Jiao Li, Ya-Ling Ma, Yu-Tao Zhao, Jian-Guo Liu

Mentions

3
Peak: 1 in Apr 2022
across 2 sources since Apr 2022

Extended reach

1,165
potential audience

Total likes

26

Video views

512

Mentions per month

Apr 2022 – Apr 2025

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The overall tone reflects a balanced appreciation of the research's significance, with posts mentioning the improvements in sperm parameters and hormone levels, as well as noting the need for larger studies. Words like 'beneficial', 'potential', and 'caution' highlight the careful consideration given to the findings, demonstrating moderate interest and engagement. The collective discussions suggest that this meta-analysis could impact clinical approaches, especially for male infertility treatment.

AgreementModerate agreement

Most discussions acknowledge the study's findings and potential implications, with some expressing cautious optimism about the use of aromatase inhibitors.

InterestModerate interest

The interested tone is moderate; posters show curiosity about the treatment options but stop short of deep enthusiasm.

EngagementModerate engagement

Comments often reference the research methods and clinical significance, indicating a genuine engagement beyond surface-level reactions.

ImpactModerate impact

The discussions suggest that the study could influence future research and clinical practice, highlighting its potential real-world effects.

Abstract in brief

  • This systematic review and meta-analysis examined the safety and effectiveness of aromatase inhibitors (AIs), specifically letrozile and anastrozole, in treating male infertility related to low testosterone and estradiol ratios, involving 10 studies with 666 patients.
  • The findings show that AIs significantly improved sperm parameters, hormone levels, and testosterone to estradiol ratio, but had limited effects compared to control treatments like SERMs or HCG, especially on sperm motility and morphology.
  • The study suggests that AIs could be beneficial for male infertility treatment, especially in improving hormone balance and sperm quality, but emphasizes the need for larger, more comprehensive studies to confirm these results.]

Top posts

Most liked on X and Bluesky
MyJournals
@myjournals · X

Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone‐estradiol ratio: a meta‐analysis and systematic review https://t.co/CnHS4nNf0f

Apr 20, 2022 · 557 followers View post →
Alex
@AlexViKu · X

Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone‐estradiol ratio: A meta‐analysis and systematic review https://t.co/OI65FozLSD

Dec 28, 2022 · 97 followers View post →

All mentions

Alex
@AlexViKu · X

Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone‐estradiol ratio: A meta‐analysis and systematic review https://t.co/OI65FozLSD

Dec 28, 2022 · 97 followers View post →
MyJournals
@myjournals · X

Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone‐estradiol ratio: a meta‐analysis and systematic review https://t.co/CnHS4nNf0f

Apr 20, 2022 · 557 followers View post →